Cortexyme, Inc. (CRTX) Social Stream
Cortexyme Inc (CRTX) Price Targets From Analysts
Use the tables below to see what analysts covering Cortexyme Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 18 months, CRTX's average price target has gone down $4.15.
CRTX reports an average of 88.69% for its upside potential over the past 18 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CRTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CRTX has a lower variance in analysts' estimates than -99.61% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Cortexyme Inc's upside potential (average analyst target price relative to current price) is higher than 197.52% of them.
- In the context of stocks in the mid market cap category, Cortexyme Inc's number of analysts covering the stock is higher than 25.63% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Cortexyme Inc's average analyst price target is higher than 152.45% of them.
Is CRTX a Buy, Hold or Sell? See the POWR Ratings now!